PharVision Advisers’s Howmet Aerospace HWM Stock Holding History

PharVision Advisers’s Portfolio HWM Stock Details HWM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,259	Closed	-$247K	–	834
2025 Q3	$247K	Buy	+1,259	New	+$229K	0.14%	343

Other funds holding HWM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PharVision Advisers's HWM Position: Q4 2025 in Review

PharVision Advisers sold out of Howmet Aerospace (HWM) in Q4 2025, closing a stake of 1,259 shares — an estimated $247K sold.

PharVision Advisers first reported a position in HWM in Q3 2025 and held it in 1 quarter. The position peaked at $247K in Q3 2025. 1,364 funds tracked by Wall St. Rank hold HWM as of Q4 2025.

PharVision Advisers reported no remaining Howmet Aerospace position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,259 Howmet Aerospace shares in Q4 2025, an estimated $247K.
PharVision Advisers first reported a position in Howmet Aerospace in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Howmet Aerospace position peaked at $247K in Q3 2025.
1,364 funds tracked by Wall St. Rank held Howmet Aerospace as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.